PREBEN, PIXANTRONE, RITUXIMAB, ETOPOSIDE AND BENDAMUSTINE, IN AGGRESSIVE NON-HOGDKIN LYMPHOMA
EHA Library, Cristina barrenetxea,
267811
A PHASE 1/1B DOSE-ESCALATION TRIAL EVALUATING CPI-818, AN ORAL INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA
EHA Library, Mehrdad Mobasher,
267823
B-SYMPTOMS, PERFORMANCE STATUS, AND RESPONSE TO FIRST THERAPY AS SURVIVAL PREDICTIVE FACTORS FOR PERIPHERAL T-CELL LYMPHOMA AT PROGRESSION/RELAPSE: A SINGLE INSTITUTE ANALYSIS
EHA Library, Yuko Shirouchi,
267785
PHARMACO-ECONOMY ANALYSIS OF THE THREATMENT WITH R-DA-EPOCH, R-CHOP, AND CHOP-LIKE REGIMENS IN HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (UKRAINIAN MULTICENTER STUDY)
EHA Library, Kateryna Filonenko,
267804
THE SIGNIFICANCE OF CD43, CD81, CD200, AND ROR1 FOR DIFFERENTIAL DIAGNOSIS OF CLL AS MULTICOLOR FLOW CYTOMETRY
EHA Library, Mesude FALAY,
267864